Tiago Girao sold $385K of Immunovant (IMVT)

Executed Jun 26, disclosed Jun 26, the same day.

Value, as filed

$385K

10,000 sh × $38.46

Executed

Jun 26

the trade date, as filed

Disclosed

Jun 26

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Tiago Girao Chief Financial Officer profile →

Tiago Girao (Chief Financial Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Immunovant, Inc. (IMVT). The largest single filing was $763K of IMVT (25,760 sh × $29.62, as filed), executed Apr 23.

The name

IMVT

Immunovant, Inc. IMVT · Healthcare · 35 filings in 24 months ticker →

Healthcare · Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Tiago Girao in IMVT

IMVTSALE Immunovant, Inc. $263K
6,798 sh × $38.69
Exec Jul 23
Filed Jul 24 · 5:57 PM ET IMVTSALE Immunovant, Inc. $763K
25,760 sh × $29.62
Exec Apr 23
Filed Apr 24 · 5:30 PM ET